Every requisite for establishing a manufacturing set-up was done from scratch. Beginning from purchase of land, installation of machines, employment of technical & managerial workforce, arrangement of water and power treatments to obtaining licenses
First Plant set-up for Oral Solid Dosage
2005-2007
In Enterprising Phase
Establishment of dedicated plant for Liquid Dosage (Plant-II) and Sterile products (Plant-III)
Achieved sales turnover of Rs. 194.47 crs. against targetted Rs.19 Cr.
Developed more than 230 products which are First Time in India or First Time In World
ISO 9001:2008 and WHO-GMP accreditations for quality production
2007-2009
Evolution
To cater demand manufcaturing ities increased for Plant-I, II & III
Setting up of Regulatory Department to prepare product dossiers
Developed 45 new Opthalmic formulations out of which 16 are First Time in India DCGI approvals
Various Opthalmic formulations converted from Suspension to Solution for better absorption, penetration & best Patient Compliance.
2009-2010
The Developments
Set-up of new plants dedicated for Sex Hormones (Plant – IV) and for Cosmetic & Derma (Plant-V)
Established dedicated line to manufacture a sensitive product in liver health. Only two sites are approved to manufacture this molecule in Drug 1st Akums in India and 2nd site in Chicago.
Developed robust processes for planning and development starting from API procurement, process optimation to validation processes.
Procurement of Sophisticated machines and equipments like Autocoaters, Tablet-in-Tablet machine, pin hole detector, T.O.C.A, Atomic Absorption Spectro-photometers, Particle size analyzer
Epoxy flooring laid down on entire premises
2010-2012
The Establishments
Establishment of Plant-VI (Maxcure) for Nutraceutical, Herbal & Ayurvedic preparations
Introduction of LIMS and SAP for to reduce inconsistency in data and increase operational efficiency
Established new Low RH Area, Beta QC & Microbiology Lab
Established huge Centralized Stability Centre comprising of 5 walk-in chambers with total 7 Lac Litres capacity
2012-2013
Build Up
Set-up of Centralized F&D Deptt. for newer FDC’s
DSIR registeration of R&D unit
National award from Govt. of India for Quality products in Pharmaceutical formulations
First Time in World product developed and commercialized with 3 releasing profiles in a Tablet
2013-2014
New Setups
Established Unosource Pharma Ltd., Mumbai for Exports
Set-up two Units – Pure & Cure Healthcare and Malik Lifesciences, Haridwar
Best Emerging Company Award and Corporate Governance Award by Business today
Developed 23 Novel Platform Technologies to enhance product efficacy
2014-2015
The Diversification
Production starts in Pure & Cure Healthcare and Malik Lifesciences, Haridwar
Received remarkable 164 Product DCGI’s on 16th July 2015
R&D unit established at Mumbai for development & registeration of products in regulated markets
UBM India Pharma Award for Excellence in Contract Manufacturing & IDMA Quality Excellence Award
2015-2017
Acceleration
Set-up of 2 new units at Guwahati to cater multiple dosage forms
Ranked 12th in Pharma Sector for India’s Next Fortune 500 Companies
During March 2017, Akums offered immediate product substitutes to Pharma Industry for 344 FDC’s which came under CDSCO review
2018-2020
Recognition
Awarded Indian Pharma Leader & National Best Employer Brand Award by 27th ET
Ranked 3rd in DRUG & PHARMACEUTICALS SECTOR
2020-2022
Extension
Akums Lifesciences Ltd. started as the manufacturer of Active Pharmaceutical Ingredients.
Akums Healthcare Pvt. Ltd, Kotdwar gave a robust Risk mitigation plan of new therapy areas.
AKUMS ICRA long term rated as AA and short term rated as A1+
Akums acquired Ankur Drugs HP plant to boost production capacities of oral tablets and liquids.